Scilex Holding Co
SCLX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.
Other share classesSCLXW
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 73
- 13F valueReported value at the end of Q2 2026
- $5.48M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SCLX, Q2 2026
No superinvestor reported holding SCLX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Scilex Holding Co insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing)8:56 AM ET | Apr 17 | 3 days | Ma Stephen HoiCFO, COO and Secretary | PPurchase | +650.0K | $0.1538 | +$100.0K | –650.0K after | Derivative |
| Apr 20, 2026 (view filing)8:52 AM ET | Apr 16 | 4 days | Ji HenryExec Chair, CEO and President | PPurchase | +3.25M | $0.1538 | +$499.9K | –3.25M after | Derivative |
| Apr 20, 2026 (view filing)8:52 AM ET | Apr 17 | 3 days | Ji HenryExec Chair, CEO and President | SSale | −650.0K | $0.1538 | −$100.0K | –2.60M after | Derivative |
| Dec 30, 2025 (view filing) | Dec 26-30 | 4 days | Scilex Holding Co10% Owner | SSale | −20.7M | $0.62 | −$12.8M | −7.8%244.4M after | 3 lots |
| Dec 18, 2024 (view filing)7:04 PM ET | Dec 18 | Same day | Shah JaisimSee Remarks | PPurchase | +30.0K | $0.46 | +$13.8K | +27.4%139.3K after | |
| Oct 31, 2024 (view filing) | Oct 31 | Same day | Ji HenryExecutive Chairperson | PPurchase | +8.89K | $0.94 | +$8.35K | +2.9%320.2K after | |
| Oct 29, 2024 (view filing) | Oct 29 | Same day | Shah JaisimSee Remarks | PPurchase | +32.0K | $0.99 | +$31.7K | +41.4%109.3K after | |
| Oct 18, 2024 (view filing) | Oct 18 | Same day | Followwill DormanDirector | PPurchase | +1.00K | $0.99 | +$990 | +76.9%2.30K after | |
| Oct 18, 2024 (view filing) | Oct 18 | Same day | Chun JayDirector | PPurchase | +5.00K | $0.95 | +$4.75K | +4.7%112.5K after | |
| Oct 18, 2024 (view filing) | Oct 17 | 1 day | Wu Yue AlexanderDirector | PPurchase | +20.0K | $0.95 | +$19.0K | +400.0%25.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Scilex Holding Co at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 301,292 | $2.35M | 0.00% | +37,242+14.1% | Added |
| BlackRock, Inc. | 109,417 | $853.5K | 0.00% | +6,621+6.4% | Added |
| Vanguard Fiduciary Trust Co | 45,822 | $357.4K | 0.00% | +6,164+15.5% | Added |
| Jacobs Levy Equity Management, Inc | 41,163 | $321.1K | 0.00% | +41,163 | New |
| State Street Corp | 35,376 | $275.9K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 33,376 | $260.3K | 0.00% | +26,908+416.0% | Added |
| Renaissance Technologies LLC | 33,064 | $257.9K | 0.00% | −3,800−10.3% | Reduced |
| Citadel Advisors LLC | 27,497 | $214.5K | 0.00% | +27,497 | New |
| Price T Rowe Associates Inc | 20,920 | $164.0K | 0.00% | +20,920 | New |
| Ashton Thomas Private Wealth, LLC | 18,482 | $144.2K | 0.00% | +493+2.7% | Added |